Hospital Surgical Disinfectant Market Size, Share & Trends Analysis Report By Product (Chlorhexidine, Alcohols, Povidone-iodine), By End-use (Hospitals, Clinics, ASCs), By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global hospital surgical disinfectant market size was valued at USD 330.83 million in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 7.0% from 2021 to 2028. A high prevalence of chronic diseases, surge in hospital-acquired infections (HAIs), increasing number of surgical procedures, rising incidence of infectious disease, and the recent outbreak of COVID-19 are among the key factors driving the market growth. The high demand for proper sanitization in medical facilities during COVID-19 has tremendously boosted the use of surgical disinfectants in hospitals, clinics, and others. For instance, the Environmental Protection Agency (EPA) has released an updated list of EPA-registered disinfectants including surgical solutions that have been qualified for use against SARS-CoV-2 in March 2020. Thus, the spread of COVID-19 necessitates the implementation of preventive measures to limit the disease's spread; as a result, hospitals are taking preventive measures. Thus, the COVID-19 pandemic has created potential opportunities for market players during the forecast period.

Moreover, HAIs are a major concern for patients as well as healthcare professionals globally. With a worldwide increase in the number of hospitalizations and HAIs, the demand for disinfection of surgical instruments is growing to minimize the risk of microbial contamination. As per the WHO estimates, hundreds of millions of patients develop HCAIs each year globally. Out of every 100 hospitalized patients, 7 in developed and 10 in developing countries are affected with at least one HAI. As a result, the rising incidence of these infections is likely to increase the demand for hospital surgical disinfectants in various healthcare facilities to limit the spread of infection. The application of disinfectant solutions in hospitals generally helps protect against contamination and lowers the risk of HAIs. This is expected to boost the market growth over the forecast period.

Furthermore, the rising number of surgical procedures in hospitals and growing awareness regarding infections and diseases are among the key factors expected to propel the market growth over the forecast period. For instance, as per the Mölnlycke Health Care AB 2019 annual report, around 70 million surgical procedures are performed each year in Europe. Similarly, according to the Healthcare Cost and Utilization Project (HCUP), in 2018, over 9,942,000 surgeries were performed in the U.S. within ambulatory care settings. In the case of surgeries, the use of surgical disinfectant products is one of the essential requirements in healthcare facilities. As these products inhibit or slow down the growth of microorganisms on the skin, these are more commonly used in hospitals and other medical settings to reduce the risk of infection during surgery and other procedures. Therefore, such instances are expected to drive the market over the forecast period.

Moreover, increasing demand for endoscopy is expected to increase the risk of getting HAIs. As per the British Society of Gastroenterology and BMJ Publishing Group Ltd. report in 2018, the demand for gastrointestinal endoscopy has grown immensely for bowel cancer screening in symptomatic patients. This is expected to drive the market for hospital surgical disinfectants over the forecast period.

The U.S. dominated the market with a revenue share of over 80.0% in 2020 owing to the high prevalence of hospital-acquired infections and an increasing number of surgeries. For instance, as per the Healthcare Information and Management Systems Society, each day, 1 out of 25 patients in the U.S. is affected by hospital-acquired infections. An increase in the number of hospitals and the prevalence of infectious diseases such as tuberculosis, dengue, malaria, and typhoid including the current pandemic of COVID-19 are expected to drive the market in the U.S. Moreover, a well-defined regulatory framework established healthcare infrastructure, and a higher adoption rate of preventive products in surgeries are some other factors fueling the market growth in the country. This is expected to positively impact the market growth during the forecast period.

Furthermore, an increase in the incidence of chronic diseases, such as cardiovascular disorders, cancer, diabetes, and other autoimmune diseases, is anticipated to boost the hospitalization rate. Increased adoption of unhealthy and sedentary lifestyles and antimicrobial resistance are some of the major factors contributing to the growing prevalence of chronic diseases. According to the U.S. National Center for Health Statistics 2018, an estimated 157 million people in America are living with chronic disease, with 81 million having multiple conditions. Thus, the rising incidence of chronic conditions has significantly increased the hospital admission rate. The healthcare facilities constantly require surgical disinfectants to keep humans and non-living things germ-free. Such factors are expected to drive the demand for hospital surgical disinfectants during the forecast period.

Product Insights

The chlorhexidine segment dominated the market in 2020 with a share of over 25.0% owing to the increased usage of formulation for pre-injection and pre-operative skin preparation. In addition, the growing demand for chlorhexidine-based products to be used in combination with other formulations, such as iodine and alcohol, is fueling the segment growth. Moreover, the demand for chlorhexidine has increased due to an increase in demand for hand rubs such as sanitizers, which are effective against different microbes.

Chlorhexidine is also expected to expand at the highest CAGR from 2021 to 2028 owing to the growing awareness and increasing applications of surgical disinfectants in pre-operation and pre-injection skin preparation during surgical procedures. Moreover, the U.S. CDC suggests that patients should be showered with an antiseptic rinse or wipe containing chlorhexidine at least the night before surgery in order to reduce infection during the procedure. It is considered to be an effective and long-lasting antiseptic as it prevents SSIs, central line-associated bloodstream infections, or other related infections. CHG has a broad spectrum in antimicrobial activity and has very rare side effects and persistent antimicrobial activity. It is used in different concentrations of 0.9%, 2%, and 4%. This increase in awareness regarding chlorhexidine benefits for hygiene and a surge in the number of surgical procedures are the other key factors that are projected to drive the segment during the forecast period.

End-use Insights

The hospitals segment dominated the overall market in terms of revenue in 2020 with a share of over 45.0%. The rising prevalence of infections and an increasing number of surgical procedures are some of the key factors driving the hospital segment. For instance, as per the CDC, every day around 1 out of 31 hospital patients acquire hospital-acquired infections. The usage of proper surgical disinfectants is essential as it helps in preventing the transmission of infections. According to a survey, maximum hospitals and healthcare centers are in Asia Pacific, thereby leading to market growth. Furthermore, increasing healthcare expenditure in developed and developing countries might increase the number of hospitals owing to which demand for surgical hospital disinfectants is also expected to increase, thereby contributing to the segment growth.

The ambulatory surgical centers segment is expected to witness lucrative growth over the forecast period. Increasing awareness regarding one-day surgeries is a major factor behind the segment growth. Owing to the increasing cost of medical procedures, people in many countries are opting for ASCs as the treatment cost in these centers is less as compared to hospitals. Increasing use of advanced surgical equipment in ASCs is attracting people to seek medical treatment at these centers. Growing different types of procedures with reimbursement opportunities is further anticipated to drive the segment. These factors are expected to drive the adoption of surgical disinfectants in ASCs, thereby boosting the segment growth over the forecast period.

Regional Insights

Asia Pacific dominated the market with a share of over 25.0% in 2020 and is expected to grow at the fastest rate from 2021 to 2028. This can be attributed to the factors such as the high prevalence of hospital-acquired infections and development in healthcare infrastructure, which boost the adoption of hospital surgical disinfectants. Moreover, regulatory policies to deliver safe and quality healthcare services are anticipated to fuel the market growth over the forecast period. For instance, the National Medical Products Administration (NMPA), which is the Chinese regulatory authority, announced that they will accelerate the registration of those medical disinfectants that meet relevant standards in the U.S., Japan, and the EU. Hence, these factors are expected to propel the growth of the market over the forecast period. Moreover, increasing diseases and surgeries in the region may further boost market growth. Maximum cases of operations and surgeries in the region are also driving the market in this region. Medical tourism in Asian countries like China, India, and Thailand is witnessing a surge. For instance, AIIMS New Delhi, India has broken the world record by having the maximum surgeries for approximately 1.97 lakhs in a year. Consumption of hospital surgical disinfectants in these countries is increasing due to improving healthcare infrastructure.

Furthermore, increasing healthcare expenditure by the public and private sectors is one of the major driving factors of the market. Such a scenario is anticipated to encourage several international and local companies to enter the regional market, thereby augmenting the growth. Moreover, major market players are making efforts to enter into untapped markets such as India, China, and Korea, thereby expanding the market scope. In addition, the rapidly increasing number of hospitals and laboratories in this region and the booming medical tourism industry are propelling market growth in the Asia Pacific region. Such factors further boost the business in the region.

Key Companies & Market Share Insights

Product modifications and extensive R&D activities are among the major competitive strategies adopted by market players. Manufacturers are trying to enhance business and increase customer base by introducing innovative solutions, which is a significant factor expected to propel the growth of the market. In addition, companies are enhancing their business presence in emerging markets through strategic alliances and agreements and focusing on strengthening distribution channels. This is further anticipated to fuel the growth of the high-level disinfection services market.

Furthermore, the increasing partnerships between regional and international players are expected to revolutionize overall hospital surgical disinfectants by driving great innovation and revenue in the market. For instance, in February 2019, Schülke & Mayr signed a distribution agreement with DKSH, one of the leading market expansion service providers. Under this agreement, DKSH will distribute and market a wide range of Schülke’s disinfectant products in China. Such a scenario is anticipated to encourage several international and local companies to enter the market, thereby augmenting the market growth. Thus, manufacturers are focusing on expanding their sales or business by broadening their product offerings or setting up new production plants in the global market. Some prominent players in the global hospital surgical disinfectant market include:

• 3M

• Ecolab

• BD

• Sage Products LLC

• B. Braun Melsungen AG

• Johnson & Johnson

• Kimberly-Clark Corporation

• Cardinal Health

• The Clorox Company

• Schülke & Mayr GmbH

Hospital Surgical Disinfectant Market Report Scope

Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global hospital surgical disinfectant market report on the basis of product, end-use, and region:

• Product Outlook (Revenue USD Million, 2016 - 2028)

  • Alcohols

  • Chlorhexidine

  • Povidone-iodine

  • Octenidine

  • Hydrogen Peroxide

  • Others

• End-use Outlook (Revenue USD Million, 2016 - 2028)

  • Hospitals

  • Clinics

  • Ambulatory Surgical Centers

  • Others

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • Germany

    • U.K.

    • France

    • Italy

    • Spain

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

  • Latin America

    • Brazil

    • Mexico

    • Argentina

    • Colombia

  • Middle East and Africa (MEA)

    • South Africa

    • Saudi Arabia

    • UAE